title: Anakinra for the inflammatory complications of chronic granulomatous disease.
authors.forename: F L
authors.initials: FL
authors.lastname: van de Veerdonk
authors.forename: M G
authors.initials: MG
authors.lastname: Netea
authors.forename: C A
authors.initials: CA
authors.lastname: Dinarello
authors.forename: J W M
authors.initials: JW
authors.lastname: van der Meer
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006105:Granulomatous Disease, Chronic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000627:therapeutic use*; D019255:NADPH Oxidases / Q000172:deficiency* / Q000276:immunology; D017382:Reactive Oxygen Species / Q000276:immunology
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D017382:Reactive Oxygen Species; D019255:NADPH Oxidases